Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis

Respiratory Medicine

Volumn 107, Issue 11, 2013, Pages 1797-1802

  Jo, Kyung Wook ^a   Hong, Yoonki ^b   Jung, Young Ju ^a   Yoo, Bin ^a   Lee, Chang Keun ^a   Kim, Yong Gil ^a   Yang, Suk Kyun ^a   Byeon, Jeong Sik ^a   Kim, Kyung Jo ^a   Ye, Byong Duk ^a   Lee, Sang Do ^a   Kim, Woo Sung ^a   Kim, Dong Soon ^a   Shim, Tae Sun ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Latent tuberculosis infection; Previous history of TB; Tumor necrosis factor

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB; ISONIAZID; LEFLUNOMIDE; MERCAPTOPURINE; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HOST RESISTANCE; HUMAN; IMMUNOTHERAPY; INCIDENCE; INFECTION RATE; INFECTION RISK; INFLAMMATORY DISEASE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; SCREENING TEST; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS; ULCERATIVE COLITIS;

LATENT TUBERCULOSIS INFECTION; PREVIOUS HISTORY OF TB; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANTITUBERCULAR AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SPONDYLITIS, ANKYLOSING; TUBERCULIN TEST; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84887087239     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.08.011     Document Type: Article

References (17)

1. ®. TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment Int J Tuberc Lung Dis 16 2012 1300 1306 http://www.ncbi.nlm.nih.gov.libproxy.amc.seoul.kr:8000/pubmed?term= combined%20use%20of%20a%20TST%20and%20T- spot%20assay%20for%20latent%20tuberculosis%20infeciton%20diagnosis
2. T. Maeda, S. Banno, and S. Maeda Comparison of QuantiFERON-TB Gold and the tuberculin skin test for detecting previous tuberculosis infection evaluated by chest CT findings in Japanese rheumatoid arthritis patients J Infect Chemother 17 2011 842 848
3. J. Perez, H. Kupper, and G. Spencer-Green Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe Ann Rheum Dis 64 Suppl. 3 2005 S265
4. J.J. Gomez-Reino, L. Carmona, and M. Angel Descalzo Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection Arthritis Rheum 57 2007 756 761
5. ®. TB assays, for the diagnosis of latent tuberculosis infection before anti-TNF-α therapy J Rheumatol 2013 [submitted for publication]
6. British Thoracic Society Standards of Care Committee BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment Thorax 60 2005 800 805
7. K.W. Jo, J.H. Woo, and Y. Hong Incidence of tuberculosis among health care workers at a private university hospital in South Korea Int J Tuberc Lung Dis 12 2008 436 440
8. F.C. Arnett, S.M. Edworthy, and D.A. Bloch The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315 324
9. S. van der Linden, H.A. Valkenburg, and A. Cats Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 1984 361 368
10. G.R. Lichtenstein, S.B. Hanauer, W.J. Sandborn Practice Parameters Committee of American College Of Gastroenterology Management of Crohn's disease in adults Am J Gastroenterol 104 2009 465 483
11. J.E. Sokal Measurement of delayed skin-testresponses N Engl J Med 293 1975 501 502
12. Korean Guideline for Tuberculosis. Available at: http://www.lungkorea. org/image/mail/file-110217.pdf [assessed December 2012].
13. J. Keane, S. Gershon, and R.P. Wise Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 2001 1098 1104
14. J.H. Kim, S.K. Cho, and M. Han Factors influencing discrepancies between the QuantiFERON-TB gold in tube test and the tuberculin skin test in Korean patients with rheumatic diseases Semin Arthritis Rheum 42 2013 424 432 http://www.ncbi.nlm.nih.gov.libproxy.amc.seoul.kr:8000/pubmed/22858451
15. Y.J. Jeong, S. Yoon, and H.K. Koo Positive tuberculin skin test or interferon-gamma release assay in patients with radiographic lesion suggesting old healed tuberculosis J Korean Med Sci 27 2012 761 766
16. F. Tubach, D. Salmon, and P. Ravaud Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies Registry Arthritis Rheum 60 2009 1884 1894
17. W.G. Dixon, K.L. Hyrich, and K.D. Watson Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) Ann Rheum Dis 69 2010 522 528